Importantly, when combined with a CD47 nanobody, IR700@Nb289‐OMVs markedly extended survival and partially eradicated tumours in subcutaneous and metastatic (lung and peritoneal cavity) CRC mouse models. This evidence concerns the gene CD47 and neoplasm.